32 related articles for article (PubMed ID: 30396956)
1. Norcycloartocarpin targets Akt and suppresses Akt-dependent survival and epithelial-mesenchymal transition in lung cancer cells.
Nonpanya N; Sanookpan K; Joyjamras K; Wichadakul D; Sritularak B; Chaotham C; Chanvorachote P
PLoS One; 2021; 16(8):e0254929. PubMed ID: 34383763
[TBL] [Abstract][Full Text] [Related]
2. Author Correction: Enhancing apoptosis-mediated anticancer activity of evodiamine through protein-based nanoparticles in breast cancer cells.
Solanki R; Rajput PK; Jodha B; Yadav UCS; Patel S
Sci Rep; 2024 Mar; 14(1):6213. PubMed ID: 38486084
[No Abstract] [Full Text] [Related]
3. Evodiamine Exhibits Anti-Bladder Cancer Activity by Suppression of Glutathione Peroxidase 4 and Induction of Ferroptosis.
Hu CY; Wu HT; Shan YS; Wang CT; Shieh GS; Wu CL; Ou HY
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37046995
[TBL] [Abstract][Full Text] [Related]
4. Evodiamine induces ROS-Dependent cytotoxicity in human gastric cancer cells via TRPV1/Ca
Liu L; Sun X; Guo Y; Ge K
Chem Biol Interact; 2022 Jan; 351():109756. PubMed ID: 34808100
[TBL] [Abstract][Full Text] [Related]
5. Evodiamine and rutaecarpine from Tetradium ruticarpum in the treatment of liver diseases.
Li X; Ge J; Zheng Q; Zhang J; Sun R; Liu R
Phytomedicine; 2020 Mar; 68():153180. PubMed ID: 32092638
[TBL] [Abstract][Full Text] [Related]
6. The Role of MMP-9 and MMP-9 Inhibition in Different Types of Thyroid Carcinoma.
Li Z; Wei J; Chen B; Wang Y; Yang S; Wu K; Meng X
Molecules; 2023 Apr; 28(9):. PubMed ID: 37175113
[TBL] [Abstract][Full Text] [Related]
7. Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers.
Panda M; Tripathi SK; Zengin G; Biswal BK
Cell Biol Toxicol; 2023 Feb; 39(1):1-31. PubMed ID: 36138312
[TBL] [Abstract][Full Text] [Related]
8. Anticancer effects of natural phytochemicals in anaplastic thyroid cancer (Review).
Li Y; Zhang J; Zhou H; Du Z
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856443
[TBL] [Abstract][Full Text] [Related]
9. A mitochondria-targeted delivery system of doxorubicin and evodiamine for the treatment of metastatic breast cancer.
Tan X; Zhou Y; Shen L; Jia H; Tan X
RSC Adv; 2019 Nov; 9(63):37067-37078. PubMed ID: 35539080
[TBL] [Abstract][Full Text] [Related]
10. Antitumor Effects of Evodiamine in Mice Model Experiments: A Systematic Review and Meta-Analysis.
Yin C; Cheng J; Peng H; Yuan S; Chen K; Li J
Front Oncol; 2021; 11():774201. PubMed ID: 34900724
[TBL] [Abstract][Full Text] [Related]
11. The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway.
Ren L; Lou Y; Sun M
Bioengineered; 2021 Dec; 12(1):5985-5995. PubMed ID: 34477479
[TBL] [Abstract][Full Text] [Related]
12. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells.
Hong Z; Wang Z; Zhou B; Wang J; Tong H; Liao Y; Zheng P; Jamshed MB; Zhang Q; Chen H
Int J Oncol; 2020 Mar; 56(3):783-793. PubMed ID: 31922213
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines.
An W; Lai H; Zhang Y; Liu M; Lin X; Cao S
Front Pharmacol; 2019; 10():758. PubMed ID: 31354479
[TBL] [Abstract][Full Text] [Related]
14. Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial-Mesenchymal Transition of Thyroid Carcinoma Cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Lee SJ
Anticancer Res; 2018 Nov; 38(11):6339-6352. PubMed ID: 30396956
[TBL] [Abstract][Full Text] [Related]
15. Evodiamine in combination with histone deacetylase inhibitors has synergistic cytotoxicity in thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Lee SJ
Endocrine; 2019 Jul; 65(1):110-120. PubMed ID: 31102069
[TBL] [Abstract][Full Text] [Related]
16. Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Endocrine; 2018 Feb; 59(2):383-394. PubMed ID: 29285650
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
